Tramadol is an synthetic opioid analgesic with some antidepressant effects. It is used to treat moderate to moderate-severe pain. It is used and metabolized in the body similarly to codeine.

Continue reading →


Methamphetamine drug testing entails an analysis of the chemical reaction performed on a biological specimen to detect the presence of methamphetamine metabolites in the person’s body. It can be done using hair, urine, blood, or oral fluid.

The most common drug test administered in the workplace and schools is urine drug testing. Methamphetamine Drug Test Strips are built into instant kits like the 10 Panel CLIA Waived Magenta Dip Card to provide rapid results. When a person has positive drug test results, it means that person has recently used methamphetamine or some other drugs.

Drug testing for methamphetamine helps authorities assess whether or not the person has recently used the drug. This is helpful, especially during forensic investigations. Parents can also administer methamphetamine drug testing through the use of methamphetamine drug test kits to ensure a drug-free family.

Detection Period

Detection period is the timeframe of how long the drugs can be detected in the biological sample. This will vary based on the drugs being tested for and by the person being tested. The detection period depends on the drug class, amount and frequency of use, age, and overall health.

According to LabCorp, for a methamphetamine urine drug test, the detection period is 3 to 5 days; for a hair test it is up to 90 days and for blood and oral fluid, it is within 12 hours.


Although some marijuana derivatives have been approved for use in chemo-induced nausea and epilepsy treatments,1 the Food and Drug Administration (FDA) has not widely approved marijuana as a safe and effective drug.2 However, state laws continue to change regarding medical and recreational marijuana. As a result, the marijuana industry may not adhere to FDA regulations prior to bringing consumer goods to market and consumers may be using products that may not be safe for human consumption like synthetic cannabinoids.3

In February 2019, more than 50 pounds of medical marijuana were recalled in coordination with the Bureau of Marijuana Regulation due to potential contamination with chemical residue, E. coli, arsenic, cadmium, and Salmonella.4 The events unfolded in Michigan, a state that passed medicinal marijuana legislation in 2008. Though the recall was voluntary, it was not the first. Just one month prior in the same state, the first 2019 recall of medical marijuana products5 brought national media coverage and questions about the safety of the drug.

Michigan’s Department of Licensing and Regulatory Affairs (LARA) published consumer information about the recalled products in its January public health and safety bulletin. The notice clarifies that manufacturers who produced the tainted drug were disposing of or retesting the recalled medical marijuana products due to concern for patients who may already have compromised immune systems.5 This is a concern echoed by experts who do not know what effects long-term use of marijuana may have on such patients.1

These recalls highlight the lack of consumer-centric, federal regulation of the marijuana manufacturing process by agencies like the FDA. In addition, the drug remains a Schedule I controlled substance as detailed by the Controlled Substances Act, which means there is no currently accepted medical use and a high potential for abuse.6

As states continue to evaluate their marijuana laws, public awareness regarding what marijuana is and isn’t should continue to be carefully considered. The National Institute on Drug Abuse supports findings that the drug is addictive, can have short- and long-term side effects, and may not be safe.7


1 National Institute on Drug Abuse (NIDA.) “Is marijuana safe and effective as medicine?”   https://www.drugabuse.gov/publications/research-reports/marijuana/marijuana-safe-effective-medicine. Updated June 2018. Accessed February 27, 2019.

2 Food and Drug Administration. “FDA and marijuana.” https://www.fda.gov/newsevents/publichealthfocus/ucm421163.htm. Update June 2018. Accessed February 27, 2019.

3 Food and Drug Administration. “Statement from FDA warning about significant health risks of contaminated illegal synthetic cannabinoid products that are being encountered by the FDA.” https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm614027.htm. Update August 2018. Accessed February 27, 2019.

4 The Detroit News. “Michigan faces health risks from tainted medical marijuana.” https://www.detroitnews.com/story/news/local/michigan/2019/02/04/michigan-risks-medical-marijuana-recalls/2636648002/. Published February 2019. Accessed February 27, 2019.

5 Michigan Department of Licensing and Regulatory Affairs. “Public Health and Safety Bulletin | Voluntary recall of marijuana products.”   https://www.michigan.gov/documents/lara/Public_Health_and_Safety_Advisory_1-4-2019_Final_642608_7.pdf. Update January 2019. Accessed February 27, 2019.

6 Drug Enforcement Agency. “Drug Scheduling”. https://www.dea.gov/drug-scheduling. Accessed February 27, 2019.

7 NIDA. “Is marijuana addictive?”  https://www.drugabuse.gov/publications/research-reports/marijuana/marijuana-addictive. Updated June 2018. Accessed February 27, 2019.


Drugs have certain “detection windows”—the amount of time after ingestion during which evidence of their use can be detected by a drug test.  Though it might not be wise to publicize detection windows and invite employees who may use drugs to push their limits, when implementing drug testing, it is important to understand them.  For instance, alcohol is absorbed and eliminated more quickly than other drugs.  This is why post-accident testing procedures often require testing for alcohol to occur within two hours.  Other drugs are eliminated from the system at different rates and thus detectable for different periods of time, often long after the drug’s effect has worn off.  The following are estimates of the length of time that certain drugs are detectable:

  • Alcohol – 1 oz. for 1.5 hours
  • Amphetamines – 48 hours
  • Barbiturates – 2-10 days
  • Benzodiazepines – 2-3 weeks
  • Cocaine – 2-10 days
  • Heroin Metabolite – less than 1 day
  • Morphine – 2-3 days
  • LSD – 8 hours
  • Marijuana – casual use, 3-4 days; chronic use, several weeks
  • Methamphetamine – 2-3 days
  • Methadone – 2-3 days
  • Phencyclidine (PCP) – 1 week

Testing conducted according to SAMHSA’s guidelines checks for five illicit drugs plus, in some cases, alcohol (ethanol, ethyl alcohol, booze).  These five illicit drugs are:

  • Amphetamines (meth, speed, crank, ecstasy)
  • THC (cannabinoids, marijuana, hash)
  • Cocaine (coke, crack)
  • Opiates (heroin, opium, codeine, morphine)
  • Phencyclidine (PCP, angel dust)

However, most private employers are not limited in the number of substances they can test for and may include drugs that individuals legitimately and/or therapeutically take based on a physician’s prescription.  Although most private employers can test for any combination of drugs, there are commonly selected “panels.”

The typical 8-Panel Test includes the above-mentioned substances plus:

  • Barbiturates (phenobarbital, butalbital, secobarbital, downers)
  • Benzodiazepines (tranquilizers like Valium, Librium, Xanax)
  • Methaqualone (Quaaludes)

The typical 10-Panel Test includes the 8-Panel Test plus:

  • Methadone (often used to treat heroin addiction)
  • Propoxyphene (Darvon compounds)

Testing can also be done for:

  • Hallucinogens (LSD, mushrooms, mescaline, peyote)
  • Inhalants (paint, glue, hairspray)
  • Anabolic steroids (synthesized, muscle-building hormones)
  • Hydrocodone (prescription medication known as Lortab, Vicodin, Oxycodone)
  • MDMA ( commonly known as Ecstasy)

Aside from a breath alcohol test, drug testing does not determine impairment or current drug use.  Rather, drug testing determines a specified amount or presence of a drug or its metabolite in urine, blood or an alternative specimen.  There is a minimum measurement applied to drug testing so that only traces of a drug or its metabolite above a specified level is reported as positive.  This measure is known as a “cut-off level,” and it varies for each drug.  Setting cut-off levels involves understanding the expected results of testing and determining the needs of the employer’s drug-free workplace program.  For instance, if a cut-off level is set low, test results will come back with more “false positives” as some “passive” users could test positive.  (For example, a low cut-off level could cause a positive result from consuming poppy seeds.)  Conversely, a high cut-off level will result in more “false negatives,” and thus some users may go undetected.  However, a high cut-off level lessens the likelihood of taking action against someone based on “passive” exposure, and for this reason SAMHSA’s guidelines set cut-off levels on the high side.


How important is it to Drug Test?

For a lot of people the answer is very easy  but in reality there is a complex issue that affects companies and their employees. For many years the war on drugs has been fought but the reality is that people still use illicit drugs but also on the rise is the use of unauthorized prescription and synthetic drugs (K2 – Synthetic Marijuana and Molly – MDMA). More than a black and white issue or an employer dictating how a employee must behave outside their work schedule, for most companies the real issue involves labor security and how drugs in the workplace impacts companies losses.

A poll from the Society of Human Resources Management showed primary reasons why companies will not conduct a drug test program in the workplace:

  • 24% Their organization didn’t believe in drug testing.
  • 18% They are not require by the state to drug test.
  • 16% The cost of drug testing is too high.
  • 16% Saw no return on their investment on a drug test policy.
  • 7% It’s too difficult to administratively manage a drug test program.
  • 2% They are planning to drug test in the future.
  • 5% Other reasons.

How does drug abuse impact the workplace?

Drugs sometimes have a financial impact on employees that consume them because their income can’t support their habit. This creates a dangerous situation to the employer in which can open the door to workplace crime and theft. According to a report sponsored by the Department of Labor, Small Business Association (SBA) and the office of National Control, lower productivity can reach 33 percent less compared to other coworkers.

From a study in 2007 by Substance Abuse and Mental Health Administration (SAMHSA) this type of worker will have a trend to change jobs more often. This can impact dramatically worker turnover in a company. This relates to cost of training, slowing down company productivity, and performance.  Data from the Society of Human Resources Management (SHRM) shows that employee turnover decreases by 16 percent when drug testing program is in place. The same data showed a drop from their respondents of 50 percent in their workers’ compensation  after they implemented a drug test program. This cost preventing measures are the reason why drug testing in the workplace is so important for companies and provides the ROI to their “Bottom Line”once the program is implemented that helps keep the work environment safer.